Baxter
BAX
$0.14 (-0.76%)
1D
1W
3M
1Y
5Y
ALL
Baxter International Inc., through its subsidiaries, provides a portfolio of essential healthcare products. The Company’s products include renal care, medication delivery, pharmaceuticals, clinical nutrition, advanced surgery and acute therapies. Its renal care offering includes peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services. Its medication delivery offerings include intravenous (IV) therapies, infusion pumps, administration sets and drug reconstitution devices. Its pharmaceuticals offerings include premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services. Its clinical nutrition offerings include parenteral nutrition (PN) therapies and related products. Its advanced surgery offerings include biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention. It also offers polysaccharide hemostatic system (PerClot) products.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
GlobeNewsWire • 1 hours ago • BAX
BAXTER INTERNATIONAL INC. (NYSE: BAX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Baxter International Inc. Investors of Upcoming Deadline
GlobeNewsWire • 1 hours ago • BAX
BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit with the Schall Law Firm
PRNewsWire • 2 hours ago • BAX
Shareholders that lost money on Baxter International, Inc.(BAX) should contact The Gross Law Firm about pending Class Action - BAX
PRNewsWire • 9 hours ago • BAX
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Baxter International Inc. with Losses of $100,000 to Contact the Firm
Seeking Alpha • 1 day ago • BAX
Macquarie Value Fund Q3 2025 Sales And Purchases
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.